Bio + Health deal partner Daisy Wolf joins Sarah Thomas, general counsel at Sameday Health, for a fireside chat on the topic of regulation in telehealth—during Covid and on.
Perhaps no area of healthcare has undergone such a rapid shift as telehealth during the Covid pandemic. But as the world emerges from the public health emergency, it's an open question what will happen with the regulatory aspects of telehealth. Daisy Wolf, deal partner at a16z Bio + Health, talked to Sarah Thomas, general counsel at Sameday Health, about asynchronous telehealth, working with regulators, how counsel thinks about inducements, and more.